FDA Inspection
Siegfried Hameln GmbHSiegfried Hameln GmbH – FDA Inspection, Jul 25, 2014
Record Details
This FDA Inspection record concerns Siegfried Hameln GmbH, with an inspection on July 25, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Siegfried Hameln GmbH
- Inspection Date
- July 25, 2014
- Product Type
- Drugs
View Company Profile
ID · 098b0d0c-6d3f-4682-8290-157ece943b50
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 887446
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.180(e)Records reviewed annually
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Siegfried Hameln GmbH
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Siegfried Hameln GmbH
- FDA Inspection 1203347 - 2022-09-01
- FDA Inspection 1050123 - 2018-04-24
- FDA Inspection 987428 - 2016-07-01
- FDA Inspection 786813 - 2012-06-14
- FDA Inspection 637807 - 2009-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.